LEADER 03882nam  2201189z- 450 
001 9910557768503321
005 20231214133410.0
035   $a(CKB)5400000000045676
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76720
035   $a(EXLCZ)995400000000045676
100   $a20202201d2021      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aRecent Developments in Cancer Systems Biology
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 electronic resource (272 p.)
311   $a3-0365-1472-4 
311   $a3-0365-1471-6 
330   $aThis ebook includes original research articles and reviews to update readers on the state of the art systems approach to not only discover novel diagnostic and prognostic biomarkers for several cancer types, but also evaluate methodologies to map out important genomic signatures. In addition, therapeutic targets and drug repurposing have been emphasized for a variety of cancer types. In particular, new and established researchers who desire to learn about cancer systems biology and why it is possibly the leading front to a personalized medicine approach will enjoy reading this book.
606   $aMedicine$2bicssc
610   $aSestrin2
610   $alung cancer
610   $aknockdown
610   $acancer progression
610   $abioinformatics
610   $apatient survival
610   $alung adenocarcinoma
610   $acirculating miR-1246
610   $aglycosaminoglycan binding
610   $aprognosis
610   $aPI3K-Akt signaling pathways
610   $aTargetScan
610   $aUBE2C
610   $acancer systems biology
610   $aexperimental model systems
610   $anext-generation sequencing
610   $asingle-cell sequencing
610   $apatient-derived xenografts
610   $apatient-derived organoids
610   $atriple-negative breast cancer
610   $apersonalized medicine
610   $acomputational methods
610   $adrug repurposing
610   $aclinical trials
610   $acancer stem cells
610   $aETS
610   $aElk-1
610   $astem cell
610   $amicroarray
610   $abrain-tumor-initiating cell (BTIC)
610   $apancreatic cancer
610   $asystems biology
610   $aomics
610   $abiomarker
610   $agenomics
610   $atranscriptomics
610   $aproteomics
610   $ametabolomics
610   $aglycomics
610   $ametagenomics
610   $aEts
610   $aPEA3
610   $aEts-1
610   $aglioma
610   $aoptical genome mapping
610   $asolid tumors
610   $acancer genomics
610   $abreast
610   $aovarian
610   $acancer
610   $aTCGA
610   $anon-small-cell lung cancer
610   $alung adenocarcinoma (LUAD)
610   $alung squamous cell carcinoma (LUSC)
610   $adifferential expression
610   $aSNV
610   $aCNV
610   $arisk group
610   $asignature
610   $asurvival
610   $arenal cancers
610   $aprotein interactome
610   $adiagnostic biomarker
610   $aprognostic biomarker
610   $avirtual screening
610   $adocking
610   $aacute myeloid leukemia
610   $aBoolean model
610   $adrug resistance
610   $anetwork
615  7$aMedicine
700   $aSinha$b Raghu$4edt$01297573
702   $aArga$b Kazim Yalcin$4edt
702   $aSinha$b Raghu$4oth
702   $aArga$b Kazim Yalcin$4oth
906   $aBOOK
912   $a9910557768503321
996   $aRecent Developments in Cancer Systems Biology$93024564
997   $aUNINA